U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06828380) titled 'A Study Comparing Immunotherapy Alone Versus Immunotherapy Combined with Radiotherapy in Patients with Hepatocellular Carcinoma (HCC) with Vascular Invasion' on Jan. 27.

Brief Summary: In the present study, we aim to investigate the efficacy and safety of concurrent therapy of Immunotherapy based combination therapy and Radiotherapy in patients with advanced HCC showing macrovascular invasion.

Study Start Date: Feb. 06

Study Type: INTERVENTIONAL

Condition: Advanced Hepatocellular Carcinoma (HCC)

Intervention: RADIATION: Particle beam radiation therapy

The prescribed dose and fractionation for proton therapy to the PTV will be...